Study strengths and limitations
Former studies showed that the outcome of neonates who had been diagnosed prenatally with a serious CHD and had consequently been offered an appropriate management in their early neonatal period had shown a better outcome in comparison with those diagnosed in their postnatal period [41]. Unfortunately, based on our study design which lacked a control group, we were not able to compare between pregnant mothers who had undergone prenatal FE and those who had not as regards to the perinatal outcome; hence we reported the outcome of our cases in a descriptive manner rather than a numerical one. Unlike many of the previous studies; it did not only include structural cardiac abnormalities but it also included fetal rhythm abnormalities. Moreover, it highlighted the different varieties of indications for FE and perinatal risk factors frequently encountered in our community. It was limited by the number of cases who did not come for follow up, so postnatal confirmation of the underlying anomaly was not done for all the studied cases.